The use of a high-energy semiconductor laser (atcus-15) in treatment of background and precancerous diseases of cervix of the uterus

In: Journal of obstetrics and women's diseases · 2005 · vol. 54(5S) , pp. 83–84 · doi:10.17816/jowd87529 · W3213818707
article OA: bronze CC0
AI-generated summary by qwen3.7-flash, 2026-09-07

Researchers evaluated the efficiency of high-energy semiconductor laser destruction for treating background and precancerous diseases of the cervix.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-09-07 · read from full text

This study evaluated the efficacy of high-energy semiconductor laser destruction for treating background and precancerous cervical conditions in 648 women aged 18 to 48. Participants underwent a multi-stage protocol involving antibiotic and antiviral therapy, followed by laser ablation using the Atkus-15 device, and concluded with immunomodulating treatment. The results indicated complete epithelialization and clearance of subclinical HPV attributes in 87% of patients within three months, while a small percentage required repeated intervention due to flaccid epithelization or relapse. Relevance to endometriosis: listed as one indication for surgical interventions in gynecology, though the paper's main focus is cervical dysplasia and HPV management.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Purpose. To study the efficiency of laser destruction in treatment of background and precancerous diseases of cervix of the uterus.
Full text 4,101 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

Purpose. To study the efficiency of laser destruction in treatment of background and precancerous diseases of cervix of the uterus. Full Text Purpose. To study the efficiency of laser destruction in treatment of background and precancerous diseases of cervix of the uterus.

Material

and methods. 648 women in the age from 18 to 48 years with various pathologies of cervix of the uterus have been examined and treated. The standard algorithm has been used, including expanded colposcopy, bacterioscopic, cytologic and morphological examination, PCR diagnostics of genital infections. STD was observed in 87% of women, HPV was observed in 38% of cases according to results of PCR. In 68% of women suffering from STD a combination of infections was observed. Most frequently revealed was a combination of HPV, ureaplasmosis and bacterial vaginosis. All patients have received a complex stage- by-stage therapy. At the first stage antibacterial medications were used, taking into account the sensitivity of pathogen, as well as antiviral, antimycotics, local antiseptics, immunocorrectors. At the second stage, cervix of the uterus was subjected to laser destruction using the high-energy semi-conductor laser Atkus-15 (with the output power from 12 to 15 Watts) on an outpatient basis, on the 5-9th day of the menstrual cycle. At the third stage, in the postoperative period, all patients received the immunomodulating therapy with lycopede, with simultaneous exposure of the wound surface to low-intensive helium-neon laser irradiation.

Results

and discussion. After the laser destruction of cervix of the uterus, the control examinations after 1, 2, and 3 months revealed a complete epithelization of cervix of the uterus and the absence of HPV sub- clinical attributes (colposcopic and cytologic) in 87% of women. 13% of patients demonstrated a flaccid epithelization which more frequently was revealed with background HPV and with a combination of various infections, requiring repeated complex treatment. Six months after treatment, in 2,5% of patients iodine-negative zones (relapse of HPV) were revealed that required repeated laser destruction. Conclusions. The use of the laser destruction method in patients of all age groups with a combination of background and inflammatory diseases of cervix of the uterus may help in future to prevent cancer development in cervix of the uterus, and can also be used to improve the reproductive health of women. About the authors L. V. Ivanova Military-medical Academy; Medical Academy. I.I. Mechnikov; Northwest Center for Laser Medicine Author for correspondence. Email: [email protected] Department of Obstetrics and Gynecology, Department of Minimally Invasive, Reconstructive Plastic, Laser Surgery of the Academy Russian Federation, Saint Petersburg; Saint Petersburg; Saint PetersburgЕ. V. Fedina Military-medical Academy; Medical Academy. I.I. Mechnikov; Northwest Center for Laser Medicine Email: [email protected] Department of Obstetrics and Gynecology, Department of Minimally Invasive, Reconstructive Plastic, Laser Surgery of the Academy Russian Federation, Saint Petersburg; Saint Petersburg; Saint PetersburgN. А. Kurganskaya Military-medical Academy; Medical Academy. I.I. Mechnikov; Northwest Center for Laser Medicine Email: [email protected] Department of Obstetrics and Gynecology, Department of Minimally Invasive, Reconstructive Plastic, Laser Surgery of the Academy Russian Federation, Saint Petersburg; Saint Petersburg; Saint Petersburg

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK